This contract expires in 206 days (Nov 9, 2026).

Browse related active opportunities

COST NO FEENO SET ASIDE USED.

THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC - TO DEVELOP A NOVEL MODULATOR TARGETING PROTEOSTASIS FOR THE TREATMENT OF M. TUBERCULOSIS.

PIID: 75N93024C00008Solicitation ID: HHS-NIH-NIAID-BAA2023-1
Signed Date: Jan 6, 2026Effective Date: May 10, 2024End Date: Closes in 206 days

Key Details

Dollars Obligated
$2.5M
Base & All Options
Awarding Sub-Agency
National Institutes of Health
Product Service Code
AN12 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Extent Competed
FULL AND OPEN COMPETITION
Number of Offers
18
Place of Performance
NEW YORK, NY, 100051338, CD-NY-10

Description

TO DEVELOP A NOVEL MODULATOR TARGETING PROTEOSTASIS FOR THE TREATMENT OF M. TUBERCULOSIS.

Contractor Information

UEI: CA1RNRESAZU6
CAGE Code: 52VM4
Location: NEW YORK, NY
View Full Record on USASpending.gov

Stay Updated

Get notified about new opportunities matching your interests.

Related